Pharmacoeconomic impact of a weight-based heparin protocol

American Journal of Health-System Pharmacy

Volumn 55, Issue SUPPL. 4, 1998, Pages

  Bowden, Carol ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; HEMOGLOBIN; HEPARIN; PROTHROMBIN; THROMBOPLASTIN;

ADULT; AGED; BLEEDING; BODY WEIGHT; BOLUS INJECTION; CLINICAL PATHWAY; CLINICAL PROTOCOL; CONFERENCE PAPER; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG COST; HEPARINIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NOMOGRAM; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; UNSTABLE ANGINA PECTORIS;

EID: 0032534910     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/55.suppl_4.s29     Document Type: Article

References (9)

1. Raschke RA, Reilly BM, Guidry JR et al. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. Ann Intern Med. 1993; 119:874-81.
2. Shalansky KE, Fitzgerald JM, Sunderji R et al. Comparison of a weight based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation. Pharmacotherapy. 1996; 16:1077-84.
3. Gunnarsson PS, Sawyer WT, Montague D et al. Appropriate use of heparin: empiric vs nomogram-based dosing. Arch Intern Med. 1995; 155:526-32.
4. Rivey MP, Peterson JP. Pharmacy-managed, weight-based heparin protocol. Am f Hasp Pharm. 1993; 50:279-84.
5. Duffy M, Kelly AM, Bav S et al. Is a standard regime for anticoagulation with heparin in unstable angina adequate? AustNZJMed. 1997; 27:665-8.
6. Hyers TM, Hull RD, Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest. 1989; 95(suppl):37S51S.
7. Hull RD, Raskob GE, Hirsh J et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engt ] Med. 1986; 315:1109-14.
8. EPILOG Investigators. Platelet glycoprotein Ilb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. NEnglfMed. 1997; 336:1689-96.
9. Bowden C, Carter K, Birtcher K et al. Pharmacoeconomic impact of a weight-based heparin protocol. Paper presented at ASHP Annual Meeting. Baltimore, MD; 1998Jun 1.